Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Molecular Templates - 19 Year Stock Price History | MTEM

Historical daily share price chart and data for Molecular Templates since 2005 adjusted for splits and dividends. The latest closing stock price for Molecular Templates as of December 27, 2024 is 0.04.
  • The all-time high Molecular Templates stock closing price was 16354.80 on April 17, 2006.
  • The Molecular Templates 52-week high stock price is 4.12, which is 10200% above the current share price.
  • The Molecular Templates 52-week low stock price is 0.04, which is 0% below the current share price.
  • The average Molecular Templates stock price for the last 52 weeks is 1.47.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Molecular Templates Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 1.6903 3.7150 4.0800 0.0440 0.0440 -98.82%
2023 6.6894 5.6985 9.3000 3.6600 3.7300 -24.19%
2022 21.9751 60.6000 61.9500 4.9200 4.9200 -91.63%
2021 120.3795 146.4000 210.7500 50.5500 58.8000 -58.25%
2020 193.8433 207.6000 273.9000 127.2000 140.8500 -32.86%
2019 105.0991 63.3000 213.0750 60.3000 209.7750 246.16%
2018 102.2119 164.2500 194.4000 50.2500 60.6000 -59.68%
2017 96.0341 77.4345 169.6500 61.0500 150.3000 106.56%
2016 86.4441 74.5965 212.8500 37.2075 72.7650 -8.11%
2015 630.4226 565.9500 843.1500 76.2300 79.1835 -84.91%
2014 664.9107 790.3500 943.8000 445.5000 524.7000 -31.91%
2013 799.0033 714.4500 965.2500 674.8500 770.5500 10.93%
2012 958.3416 227.7000 1475.0999 212.8500 694.6500 245.08%
2011 278.4070 305.2500 453.7500 199.6500 201.3000 -9.62%
2010 243.7348 297.0000 376.2000 163.2675 222.7335 -25.01%
2009 260.2846 97.3500 590.7000 90.7500 297.0000 215.79%
2008 302.0675 544.5000 633.6000 56.1000 94.0500 -82.08%
2007 1439.2864 3375.8999 3791.6998 514.8000 524.7000 -85.68%
2006 6973.8200 14750.9994 16354.7993 1435.4999 3662.9999 -74.39%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $0.057B
Molecular Templates Inc. is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies for the treatment of cancers and other serious diseases. Molecular Templates Inc., formerly known as Threshold Pharmaceuticals Inc., is headquartered in Austin, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $77.104B 29.67
Chugai Pharmaceutical (CHGCY) Japan $71.119B 28.07
Takeda Pharmaceutical (TAK) Japan $42.605B 9.43
Sandoz Group AG (SDZNY) Switzerland $21.019B 0.00
Merck (MKKGY) Germany $19.580B 17.53
Astellas Pharma (ALPMY) Japan $17.518B 16.13
Summit Therapeutics (SMMT) United States $15.855B 0.00
United Therapeutics (UTHR) United States $15.678B 15.42
Neurocrine Biosciences (NBIX) United States $15.371B 40.70
Shionogi (SGIOY) Japan $12.999B 0.00
Orion OYJ (ORINY) Finland $7.681B 21.59
Madrigal Pharmaceuticals (MDGL) United States $7.302B 0.00
Corcept Therapeutics (CORT) United States $7.012B 53.11
Stevanato Group S.p.A (STVN) Italy $6.787B 43.94
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.911B 0.00
Ionis Pharmaceuticals (IONS) United States $5.037B 0.00
Grifols, S.A (GRFS) Spain $4.737B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.331B 6.88
Crinetics Pharmaceuticals (CRNX) United States $3.737B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.829B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.691B 12.19
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.559B 15.30
Centessa Pharmaceuticals (CNTA) United Kingdom $2.231B 0.00
Soleno Therapeutics (SLNO) United States $2.166B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.059B 0.00
Hypermarcas (HYPMY) Brazil $1.957B 0.00
Indivior (INDV) United States $1.641B 6.69
BioCryst Pharmaceuticals (BCRX) United States $1.636B 0.00
Evotec AG (EVO) Germany $1.602B 0.00
Dyne Therapeutics (DYN) United States $1.447B 0.00
Guardian Pharmacy Services (GRDN) United States $1.444B 0.00
Xencor (XNCR) United States $1.279B 0.00
Ardelyx (ARDX) United States $1.270B 0.00
ARS Pharmaceuticals (SPRY) United States $1.265B 0.00
Ocular Therapeutix (OCUL) United States $1.211B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.138B 0.00
Harrow (HROW) United States $1.094B 0.00
Enliven Therapeutics (ELVN) United States $1.068B 0.00
Collegium Pharmaceutical (COLL) United States $1.036B 5.65
Bioventus (BVS) United States $0.867B 27.39
Avadel Pharmaceuticals (AVDL) Ireland $0.761B 0.00
Relay Therapeutics (RLAY) United States $0.748B 0.00
Cronos Group (CRON) Canada $0.726B 0.00
Verve Therapeutics (VERV) United States $0.644B 0.00
USANA Health Sciences (USNA) United States $0.621B 11.51
Elite Pharmaceuticals (ELTP) United States $0.534B 0.00
Xeris Biopharma Holdings (XERS) United States $0.531B 0.00
Akebia Therapeutics (AKBA) United States $0.489B 0.00
ProKidney (PROK) United States $0.481B 0.00
Altimmune (ALT) United States $0.472B 0.00
Oruka Therapeutics (ORKA) United States $0.471B 0.00
Savara (SVRA) United States $0.463B 0.00
Organogenesis (ORGO) United States $0.463B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.461B 0.00
OmniAb (OABI) United States $0.455B 0.00
KalVista Pharmaceuticals (KALV) United States $0.440B 0.00
Siga Technologies (SIGA) United States $0.427B 4.98
Zevra Therapeutics (ZVRA) United States $0.418B 0.00
Tourmaline Bio (TRML) United States $0.412B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.381B 154.64
Ironwood Pharmaceuticals (IRWD) United States $0.374B 0.00
Esperion Therapeutics (ESPR) United States $0.353B 0.00
Korro Bio (KRRO) United States $0.320B 0.00
Aldeyra Therapeutics (ALDX) United States $0.312B 0.00
Aquestive Therapeutics (AQST) United States $0.275B 0.00
4D Molecular Therapeutics (FDMT) United States $0.259B 0.00
Heron Therapeutics (HRTX) United States $0.259B 0.00
Nature's Sunshine Products (NATR) United States $0.257B 15.29
Amylyx Pharmaceuticals (AMLX) United States $0.250B 0.00
Larimar Therapeutics (LRMR) United States $0.245B 0.00
Innate Pharma SA (IPHYF) France $0.243B 0.00
CytoDyn (CYDY) United States $0.243B 0.00
Avita Medical (RCEL) United States $0.239B 0.00
MediWound (MDWD) Israel $0.211B 0.00
Profound Medical (PROF) Canada $0.194B 0.00
Acrivon Therapeutics (ACRV) United States $0.189B 0.00
Lexeo Therapeutics (LXEO) United States $0.180B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.179B 0.00
Aclaris Therapeutics (ACRS) United States $0.177B 0.00
Lyell Immunopharma (LYEL) United States $0.172B 0.00
Nanobiotix S.A (NBTX) France $0.164B 0.00
Silence Therapeutics (SLN) United Kingdom $0.160B 0.00
Inhibikase Therapeutics (IKT) United States $0.157B 0.00
VAXART, INC (VXRT) United States $0.155B 0.00
Nektar Therapeutics (NKTR) United States $0.153B 0.00
Champions Oncology (CSBR) United States $0.152B 0.00
Telomir Pharmaceuticals (TELO) United States $0.144B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.119B 0.00
Cardiol Therapeutics (CRDL) Canada $0.116B 0.00
Cassava Sciences (SAVA) United States $0.115B 0.00
Achieve Life Sciences (ACHV) Canada $0.112B 0.00
Inotiv (NOTV) United States $0.111B 0.00
ElectroCore (ECOR) United States $0.111B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.109B 0.00
Protara Therapeutics (TARA) United States $0.102B 0.00
Metagenomi (MGX) United States $0.101B 0.00
Journey Medical (DERM) United States $0.095B 0.00
Pyxis Oncology (PYXS) United States $0.093B 0.00
Nutriband (NTRB) United States $0.092B 0.00
Fractyl Health (GUTS) United States $0.089B 0.00
Avalo Therapeutics (AVTX) United States $0.088B 0.00
Arch Biopartners (ACHFF) Canada $0.082B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.080B 0.00
AleAnna (ANNA) United States $0.080B 0.00
Karyopharm Therapeutics (KPTI) United States $0.079B 0.00
Galectin Therapeutics (GALT) United States $0.078B 0.00
Assertio Holdings (ASRT) United States $0.077B 20.07
ESSA Pharma (EPIX) Canada $0.076B 0.00
PMV Pharmaceuticals (PMVP) United States $0.073B 0.00
Vivani Medical (VANI) United States $0.070B 0.00
Century Therapeutics (IPSC) United States $0.070B 0.00
Context Therapeutics (CNTX) United States $0.069B 0.00
Regulus Therapeutics (RGLS) United States $0.066B 0.00
Mural Oncology (MURA) Ireland $0.064B 0.00
Unicycive Therapeutics (UNCY) United States $0.064B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.063B 0.00
Prelude Therapeutics (PRLD) United States $0.061B 0.00
OptiNose (OPTN) United States $0.060B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Rafael Holdings (RFL) United States $0.051B 0.00
FibroGen (FGEN) United States $0.049B 0.00
NRx Pharmaceuticals (NRXP) United States $0.047B 0.00
AlloVir (ALVR) United States $0.047B 0.00
Iterum Therapeutics (ITRM) Ireland $0.044B 0.00
SCYNEXIS (SCYX) United States $0.041B 0.00
Tempest Therapeutics (TPST) United States $0.040B 0.00
CASI Pharmaceuticals (CASI) China $0.038B 0.00
Surrozen (SRZN) United States $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.035B 0.00
Jupiter Neurosciences (JUNS) United States $0.034B 0.00
Scienture Holdings (SCNX) United States $0.034B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.032B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.030B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.030B 0.00
Incannex Healthcare (IXHL) Australia $0.029B 0.00
BioVie (BIVI) United States $0.029B 0.00
PolyPid (PYPD) Israel $0.029B 0.00
Natural Alternatives (NAII) United States $0.027B 0.00
Traws Pharma (TRAW) United States $0.027B 0.00
DURECT (DRRX) United States $0.024B 0.00
Enlivex Therapeutics (ENLV) Israel $0.024B 0.00
Vivos Therapeutics (VVOS) United States $0.023B 0.00
Citius Pharmaceuticals (CTXR) United States $0.023B 0.00
Lipocine (LPCN) United States $0.023B 0.00
Dominari Holdings (DOMH) United States $0.022B 0.00
Mannatech (MTEX) United States $0.022B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
Carisma Therapeutics (CARM) United States $0.019B 0.00
MEI Pharma (MEIP) United States $0.019B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Cosmos Health (COSM) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
TherapeuticsMD (TXMD) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
Lyra Therapeutics (LYRA) United States $0.012B 0.00
Nuvilex (PMCB) United States $0.011B 0.00
Talphera (TLPH) United States $0.011B 0.00
Relmada Therapeutics (RLMD) United States $0.011B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Klotho Neurosciences (KLTO) United States $0.010B 0.00
Ainos (AIMD) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.010B 0.00
Indaptus Therapeutics (INDP) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Redhill Biopharma (RDHL) Israel $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
BioLineRx (BLRX) Israel $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
ProPhase Labs (PRPH) United States $0.006B 0.00
Viracta Therapeutics (VIRX) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Clearmind Medicine (CMND) Canada $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
Bio-Path Holdings (BPTH) United States $0.005B 0.00
SciSparc (SPRC) Israel $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.004B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.07
Alaunos Therapeutics (TCRT) United States $0.003B 0.00
SHINECO (SISI) China $0.003B 0.00
Conduit Pharmaceuticals (CDT) United States $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Heatwurx (PCSA) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
China SXT Pharmaceuticals (SXTC) China $0.002B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Aditxt (ADTX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.001B 0.00
PainReform (PRFX) Israel $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00